SCHEMBL24048566

SCHEMBL24048566

Clc1c(Br)ccc2c1oc1c3ccccc3ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 9/20 0.42
▸ CYP1A2 P05177 9/20 0.42
▸ CYP1B1 Q16678 9/20 0.42
▸ MAPT P10636 3/20 0.42
▸ HTT P42858 2/20 0.42
▸ PAX8 Q06710 1/20 0.42
▸ KMT2A Q03164 1/20 0.41
▸ ARSA P15289 1/20 0.41
▸ CDC25A P30304 1/20 0.41
▸ CDC25C P30307 1/20 0.41
▸ CYP2A6 P11509 1/20 0.41
▸ KDM4E B2RXH2 4/20 0.40
▸ HPGD P15428 4/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ PDE5A O76074 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ ABCB1 P08183 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24048559 0.82 L3MBTL1 (0.41) CYP1A1CYP1A2MAPTPAX8KMT2A
SCHEMBL30154375 0.81 HPRT1 (0.57) CYP1A1CYP1A2CYP1B1MAPTHTT
SCHEMBL5470220 0.81 HPRT1 (0.57) CYP1A1CYP1A2CYP1B1MAPTHTT
SCHEMBL17383046 0.80 KMT2A (0.45) CYP1A1CYP1A2CYP1B1MAPTHTT
SCHEMBL30057312 0.80 KMT2A (0.45) CYP1A1CYP1A2CYP1B1MAPTHTT
SCHEMBL30133063 0.80 CYP1A2 (0.43) CYP1A1CYP1A2CYP1B1MAPTHTT
SCHEMBL23597240 0.80 CYP1A2 (0.43) CYP1A1CYP1A2CYP1B1MAPTHTT
SCHEMBL23597259 0.79 CYP1A1 (0.49) CYP1A1CYP1A2CYP1B1MAPTHTT
SCHEMBL23597466 0.79 CYP1A1 (0.43) CYP1A1CYP1A2CYP1B1MAPTHTT
SCHEMBL17383112 0.79 KMT2A (0.47) CYP1A1CYP1A2CYP1B1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337531-A1 NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2023-10-19 — — US disclosed
US-20230337531-A1 NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2023-10-19 — — US disclosed
WO-2021235830-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME 주식회사 엘지화학 2021-11-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337531-A1 NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, AHR, CRY2 CYP1A1 21/4885CYP1A2 127/4885CYP1B1 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback